603718 海利生物
已收盘 02-03 15:00:00
资讯
新帖
简况
2月3日海利生物(603718)龙虎榜数据
证券之星 · 17:51
2月3日海利生物(603718)龙虎榜数据
股市必读:海利生物(603718)2月2日收盘跌停,主力净流出1061.77万元
证券之星 · 01:50
股市必读:海利生物(603718)2月2日收盘跌停,主力净流出1061.77万元
每周股票复盘:海利生物(603718)2025年净利预盈1100万至1600万元
证券之星 · 02-01 03:15
每周股票复盘:海利生物(603718)2025年净利预盈1100万至1600万元
海利生物(603718)披露公司股票可能被实施退市风险警示的风险提示公告,1月30日股价下跌1.52%
证券之星 · 01-30
海利生物(603718)披露公司股票可能被实施退市风险警示的风险提示公告,1月30日股价下跌1.52%
每周股票复盘:海利生物(603718)完成工商变更及子公司生产许可证更新
证券之星 · 01-25
每周股票复盘:海利生物(603718)完成工商变更及子公司生产许可证更新
海利生物(603718)披露全资子公司医疗器械生产许可证变更公告,01月22日股价上涨0.31%
证券之星 · 01-22
海利生物(603718)披露全资子公司医疗器械生产许可证变更公告,01月22日股价上涨0.31%
海利生物(603718)披露完成工商变更登记公告,1月19日股价上涨0.78%
证券之星 · 01-19
海利生物(603718)披露完成工商变更登记公告,1月19日股价上涨0.78%
每周股票复盘:海利生物(603718)回购注销375.75万股
证券之星 · 01-18
每周股票复盘:海利生物(603718)回购注销375.75万股
海利生物完成部分限制性股票回购注销,总股本缩减至约6.52亿股
中金财经 · 01-13
海利生物完成部分限制性股票回购注销,总股本缩减至约6.52亿股
每周股票复盘:海利生物(603718)拟注销375.75万股限制性股票
证券之星 · 01-11
每周股票复盘:海利生物(603718)拟注销375.75万股限制性股票
海利生物(603718)披露限制性股票回购注销实施公告,1月6日股价下跌1.98%
证券之星 · 01-06
海利生物(603718)披露限制性股票回购注销实施公告,1月6日股价下跌1.98%
每周股票复盘:海利生物(603718)控股子公司拟收购七家口腔连锁公司
证券之星 · 01-02
每周股票复盘:海利生物(603718)控股子公司拟收购七家口腔连锁公司
海利生物(603718)披露控股子公司收购扬州、常州七家口腔连锁公司股权,12月31日股价下跌0.16%
证券之星 · 2025-12-31
海利生物(603718)披露控股子公司收购扬州、常州七家口腔连锁公司股权,12月31日股价下跌0.16%
海利生物(603718)披露收购控股子公司少数股东权益进展暨完成工商变更登记,12月18日股价上涨1.29%
证券之星 · 2025-12-18
海利生物(603718)披露收购控股子公司少数股东权益进展暨完成工商变更登记,12月18日股价上涨1.29%
海利生物股东会通过收购子公司少数股权议案,整合资源提升控制力
中金财经 · 2025-12-17
海利生物股东会通过收购子公司少数股权议案,整合资源提升控制力
海利生物(603718.SH)子公司天然骨移植材料产品获MOH批准
智通财经 · 2025-12-16
海利生物(603718.SH)子公司天然骨移植材料产品获MOH批准
海利生物“债转股”收购迷雾:估值腰斩、承诺缩水,中小股东利益谁来守护?
新浪证券 · 2025-12-12
海利生物“债转股”收购迷雾:估值腰斩、承诺缩水,中小股东利益谁来守护?
异动快报:海利生物(603718)12月11日13点5分触及跌停板
证券之星 · 2025-12-11
异动快报:海利生物(603718)12月11日13点5分触及跌停板
海利生物(603718)披露拟收购控股子公司少数股权,12月05日股价上涨1.7%
证券之星 · 2025-12-05
海利生物(603718)披露拟收购控股子公司少数股权,12月05日股价上涨1.7%
海利生物最新公告:收购瑞盛生物少数股东权益无需支付股权转让款
证券之星 · 2025-11-30
海利生物最新公告:收购瑞盛生物少数股东权益无需支付股权转让款
加载更多
公司概况
公司名称:
上海海利生物技术股份有限公司
所属行业:
医药制造业
上市日期:
2015-05-15
主营业务:
上海海利生物技术股份有限公司的主营业务是体外诊断试剂(IVD)业务板块和口腔组织修复与再生材料业务板块。公司的主要产品是体外诊断试剂、口腔组织修复与再生材料。公司子公司捷门生物被认定为“上海市专精特新中小企业”、“上海市科技小巨人培育企业”,控股子公司瑞盛生物是陕西省瞪羚企业、陕西省“专精特新”中小企业和陕西省工业企业研发机构。
发行价格:
6.81
{"stockData":{"symbol":"603718","market":"SH","secType":"STK","nameCN":"海利生物","latestPrice":5.26,"timestamp":1770102001000,"preClose":5.84,"halted":0,"volume":8685500,"delay":0,"changeRate":-0.0993,"floatShares":649000000,"shares":652000000,"eps":0.2629,"marketStatus":"已收盘","change":-0.58,"latestTime":"02-03 15:00:00","open":5.26,"high":5.26,"low":5.26,"amount":45685700,"amplitude":0,"askPrice":5.26,"askSize":518978,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.2629,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770168600000},"marketStatusCode":5,"adr":0,"adjPreClose":5.84,"symbolType":"stock","openAndCloseTimeList":[[1770082200000,1770089400000],[1770094800000,1770102000000]],"highLimit":6.42,"lowLimit":5.26,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":651904700,"isCdr":false,"pbRate":2.24,"roa":"--","peRate":20.007607,"roe":"1.29%","epsLYR":0.27,"committee":0,"marketValue":3429000000,"turnoverRate":0.0134,"status":1,"floatMarketCap":3414000000},"requestUrl":"/m/hq/s/603718","defaultTab":"news","newsList":[{"id":"2608824513","title":"2月3日海利生物(603718)龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2608824513","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608824513?lang=zh_cn&edition=full","pubTime":"2026-02-03 17:51","pubTimestamp":1770112301,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年2月3日公布的交易公开信息显示,海利生物因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年2月3日收盘,海利生物报收于5.26元,下跌9.93%,已连续跌停2天,换手率1.34%,成交量8.69万手,成交额4568.57万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300031006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603718","BK0239","BK0070"],"gpt_icon":0},{"id":"2608203899","title":"股市必读:海利生物(603718)2月2日收盘跌停,主力净流出1061.77万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608203899","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608203899?lang=zh_cn&edition=full","pubTime":"2026-02-03 01:50","pubTimestamp":1770054623,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘,海利生物报收于5.84元,下跌10.02%,跌停,换手率1.3%,成交量8.45万手,成交额4932.29万元。当日关注点来自交易信息汇总:海利生物2月2日收盘报5.84元,跌停,当日成交844.57万元,主力资金净流出1061.77万元,占总成交额21.53%。交易信息汇总股价提醒2月2日海利生物收盘报5.84元,跌停,当日成交844.57万元。前10个交易日资金流向情况:主力资金累计净流出5936.76万元,股价累计下跌9.62%;融资余额累计减少954.6万元,融券余量累计增加1.18万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300001156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0046","BK0239","603718"],"gpt_icon":0},{"id":"2608607726","title":"每周股票复盘:海利生物(603718)2025年净利预盈1100万至1600万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608607726","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608607726?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:15","pubTimestamp":1769886914,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,海利生物报收于6.49元,较上周的6.55元下跌0.92%。业绩披露要点海利生物发布业绩预告,预计2025年全年归属净利润盈利1100万元至1600万元,扣非后净利润亏损3.9亿元至4亿元,扣除后营业收入为19,000万元至19,500万元。公司公告汇总上海海利生物技术股份有限公司预计2025年年度实现利润总额3,400万元到4,000万元,归属于母公司所有者的净利润1,100万元到1,600万元,扣除非经常性损益后的净利润为-40,000万元到-39,000万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718","BK0046","BK0239","BK0070"],"gpt_icon":0},{"id":"2607304477","title":"海利生物(603718)披露公司股票可能被实施退市风险警示的风险提示公告,1月30日股价下跌1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607304477","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607304477?lang=zh_cn&edition=full","pubTime":"2026-01-30 23:06","pubTimestamp":1769785581,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,海利生物报收于6.49元,较前一交易日下跌1.52%,最新总市值为42.31亿元。近日,海利生物发布《关于公司股票可能被实施退市风险警示的风险提示公告》。公司已于2026年1月31日发布首次风险提示公告,后续将至少再披露两次。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000048016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603718","BK0070","BK0046"],"gpt_icon":0},{"id":"2606373972","title":"每周股票复盘:海利生物(603718)完成工商变更及子公司生产许可证更新","url":"https://stock-news.laohu8.com/highlight/detail?id=2606373972","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606373972?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:26","pubTimestamp":1769282772,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,海利生物报收于6.55元,较上周的6.41元上涨2.18%。本周,海利生物1月23日盘中最高价报6.55元。本周关注点公司公告汇总:海利生物完成工商变更登记,取消监事会,变更注册地址与经营范围,并修订公司章程。海利生物关于全资子公司医疗器械生产许可证变更的公告上海海利生物技术股份有限公司全资子公司上海捷门生物技术有限公司近日收到上海市药品监督管理局换发的《医疗器械生产许可证》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603718","BK0046","BK0070"],"gpt_icon":0},{"id":"2605497444","title":"海利生物(603718)披露全资子公司医疗器械生产许可证变更公告,01月22日股价上涨0.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605497444","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605497444?lang=zh_cn&edition=full","pubTime":"2026-01-22 22:32","pubTimestamp":1769092340,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘,海利生物报收于6.47元,较前一交易日上涨0.31%,最新总市值为42.18亿元。公司近日发布公告称,其全资子公司上海捷门生物技术有限公司收到上海市药品监督管理局换发的《医疗器械生产许可证》。本次变更包括许可证有效期延长至2031年1月3日,以及生产地址变更为上海市嘉定区恒裕路66弄1号102室、202室、502室。本次变更系许可证到期延续及生产地址正常变更,对公司生产经营无重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200041038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1583","BK1574","09996","BK1222","BK1100","BK0046","09997","BK0239","BK0070","603718"],"gpt_icon":0},{"id":"2604182857","title":"海利生物(603718)披露完成工商变更登记公告,1月19日股价上涨0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604182857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604182857?lang=zh_cn&edition=full","pubTime":"2026-01-19 17:35","pubTimestamp":1768815319,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘,海利生物报收于6.46元,较前一交易日上涨0.78%,最新总市值为42.11亿元。该股当日开盘6.41元,最高6.47元,最低6.39元,成交额达5096.19万元,换手率为1.22%。近日,海利生物发布关于完成工商变更登记的公告。公告显示,上海海利生物技术股份有限公司已完成工商变更登记,取消监事会,变更注册地址和经营范围,并修订公司章程。公司因限制性股票回购注销,注册资本由655,662,200元变更为651,904,700元,股份总数由655,662,200股变更为651,904,700股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900024000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0046","BK0239","603718"],"gpt_icon":0},{"id":"2604923925","title":"每周股票复盘:海利生物(603718)回购注销375.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604923925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604923925?lang=zh_cn&edition=full","pubTime":"2026-01-18 04:00","pubTimestamp":1768680036,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘,海利生物报收于6.41元,较上周的6.48元下跌1.08%。本周,海利生物1月13日盘中最高价报6.8元。本周关注点公司公告汇总:海利生物完成3,757,500股限制性股票回购注销,总股本由655,662,200股变更为651,904,700股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0070","603718","BK0239"],"gpt_icon":0},{"id":"2603522205","title":"海利生物完成部分限制性股票回购注销,总股本缩减至约6.52亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603522205","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603522205?lang=zh_cn&edition=full","pubTime":"2026-01-13 07:58","pubTimestamp":1768262335,"startTime":"0","endTime":"0","summary":"中访网数据 上海海利生物技术股份有限公司于近日完成了2023年股权激励计划中部分限制性股票的回购注销工作。本次回购注销事宜已获得公司董事会审议通过,并履行了通知债权人等法定程序。此次回购注销完成后,公司总股本由655,662,200股减少至651,904,700股,其中有限售条件股份减少至2,925,000股。此次回购注销是基于激励计划相关条款的常规操作,旨在维护公司股权激励制度的严肃性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260113/31935667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","BK0046","BK0070","603718"],"gpt_icon":0},{"id":"2602535496","title":"每周股票复盘:海利生物(603718)拟注销375.75万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2602535496","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602535496?lang=zh_cn&edition=full","pubTime":"2026-01-11 03:07","pubTimestamp":1768072028,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,海利生物报收于6.48元,较上周的6.1元上涨6.23%。本周,海利生物1月5日盘中最高价报6.71元。本周关注点公司公告汇总:海利生物拟回购注销375.75万股限制性股票,涉及离职人员及未达解除限售条件。股本股东变化:本次回购注销后,公司总股本将由655,662,200股减至651,904,700股。其中,离职人员涉及132万股,第二个解除限售期未达标涉及243.75万股。本次回购注销已于2025年10月28日经董事会审议通过,无需提交股东大会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603718","BK0046","BK0070"],"gpt_icon":0},{"id":"2601813460","title":"海利生物(603718)披露限制性股票回购注销实施公告,1月6日股价下跌1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601813460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601813460?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:28","pubTimestamp":1767709702,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘,海利生物报收于6.45元,较前一交易日下跌1.98%,最新总市值为42.29亿元。公司近日发布公告称,上海海利生物技术股份有限公司因激励对象8人离职及第二个解除限售期条件未成就,决定回购注销限制性股票合计375.75万股。其中,离职人员涉及132万股,第二个解除限售期未达标涉及243.75万股。本次回购注销已于2025年10月28日经董事会审议通过,无需提交股东大会审议。回购注销完成后,公司总股本将由655,662,200股减至651,904,700股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600042576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","603718","BK0046"],"gpt_icon":0},{"id":"2600036093","title":"每周股票复盘:海利生物(603718)控股子公司拟收购七家口腔连锁公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2600036093","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600036093?lang=zh_cn&edition=full","pubTime":"2026-01-02 03:33","pubTimestamp":1767295988,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,海利生物报收于6.21元,较上周的6.36元下跌2.36%。海利生物关于控股子公司收购扬州、常州七家口腔连锁公司股权的公告上海海利生物技术股份有限公司控股子公司瑞盛生物拟以自有资金6,120万元收购扬州、常州七家口腔连锁公司各51%股权。本次交易完成后,七家公司将成为瑞盛生物控股子公司,公司二级子公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","603718","BK0239","BK0046"],"gpt_icon":0},{"id":"2595775537","title":"海利生物(603718)披露控股子公司收购扬州、常州七家口腔连锁公司股权,12月31日股价下跌0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595775537","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595775537?lang=zh_cn&edition=full","pubTime":"2025-12-31 22:22","pubTimestamp":1767190941,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,海利生物报收于6.1元,较前一交易日下跌0.16%,最新总市值为40亿元。该股当日开盘6.16元,最高6.16元,最低6.08元,成交额达3877.59万元,换手率为0.98%。近日,海利生物发布关于控股子公司收购扬州、常州七家口腔连锁公司股权的公告。本次交易采用分期付款方式,首期支付85%,剩余15%在业绩承诺期满后根据完成情况支付。交易已获公司董事会审议通过,不构成重大资产重组。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100044876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603718","BK0046","BK0070"],"gpt_icon":0},{"id":"2592902436","title":"海利生物(603718)披露收购控股子公司少数股东权益进展暨完成工商变更登记,12月18日股价上涨1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592902436","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592902436?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:43","pubTimestamp":1766068993,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘,海利生物报收于6.26元,较前一交易日上涨1.29%,最新总市值为41.04亿元。近日,海利生物发布关于收购控股子公司少数股东权益进展暨完成工商变更登记的公告。公告显示,上海海利生物技术股份有限公司已完成收购陕西瑞盛生物科技有限公司少数股东权益的工商变更登记。本次变更后,公司持有瑞盛生物股权比例由55%增至96%,瑞盛生物仍为公司控股子公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800039278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603718","BK0046","BK0070"],"gpt_icon":0},{"id":"2592995921","title":"海利生物股东会通过收购子公司少数股权议案,整合资源提升控制力","url":"https://stock-news.laohu8.com/highlight/detail?id=2592995921","media":"中金财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592995921?lang=zh_cn&edition=full","pubTime":"2025-12-17 08:53","pubTimestamp":1765932799,"startTime":"0","endTime":"0","summary":"中访网数据 上海海利生物技术股份有限公司于2025年12月16日召开了2025年第三次临时股东会。本次会议的核心议题是审议《关于收购控股子公司少数股东权益的议案》。根据表决结果,该议案获得高票通过,同意票数约为2.58亿股,占出席会议有效表决权股份总数的99.3730%。此次收购旨在进一步整合公司资源,加强对子公司的控制与管理,优化业务结构。此次决议的落实预计将对海利生物未来的业务发展和财务状况产生积极影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251217/31870732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0046","BK0239","BK0070","603718"],"gpt_icon":0},{"id":"2591602010","title":"海利生物(603718.SH)子公司天然骨移植材料产品获MOH批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2591602010","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591602010?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:53","pubTimestamp":1765875208,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海利生物(603718.SH)公告,公司控股子公司陕西瑞盛生物科技有限公司(简称“瑞盛生物”)于2025年8月向印度尼西亚卫生部(简称“MOH”)递交了瑞盛生物GORORISE Natural Bone Grafting Material (GORORISE天然骨移植材料)产品的注册申报资料。瑞盛生物于近日收到MOH通知,瑞盛生物的GORORISE天然骨移植材料产品获得MOH的批准。本次获得印度尼西亚注册证的GORORISE天然骨移植材料是瑞盛生物研发和生产的一种动物源性骨修复材料,在组成成分和微观结构上均与人体天然骨组织高度相似。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","MOH","SG9999014013.SGD","BK4585","BK4154","BK0070","SG9999014005.SGD","BK4532","SG9999014021.USD","BK0239","SG9999014039.USD","BK4588","603718"],"gpt_icon":0},{"id":"2590257579","title":"海利生物“债转股”收购迷雾:估值腰斩、承诺缩水,中小股东利益谁来守护?","url":"https://stock-news.laohu8.com/highlight/detail?id=2590257579","media":"新浪证券","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590257579?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:25","pubTimestamp":1765527900,"startTime":"0","endTime":"0","summary":" 一纸以股权抵偿交易差价的协议,让海利生物再次成为资本市场关注的焦点。公司近日宣布,将以约3.993亿元的对价收购子公司瑞盛生物剩余41%股权,而该笔款项实际为之前收购差价形成的“债转股”。 海利生物此次“以股抵债”式收购,虽在表面上控制了现金支出风险,却暴露出标的业绩不稳定、交易对手资信薄弱、估值调整滞后、关联交易透明度不足等多重隐患。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2025-12-12/doc-inhaprxi5673997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0070","BK0239","603718","BK0046"],"gpt_icon":0},{"id":"2590618095","title":"异动快报:海利生物(603718)12月11日13点5分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2590618095","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590618095?lang=zh_cn&edition=full","pubTime":"2025-12-11 13:10","pubTimestamp":1765429841,"startTime":"0","endTime":"0","summary":"证券之星12月11日盘中消息,13点5分海利生物(603718)触及跌停板。其所属行业动物保健目前下跌。领涨股为回盛生物。该股为医药,疫苗,动物保健概念热股。12月10日的资金流向数据方面,主力资金净流出899.94万元,占总成交额7.36%,游资资金净流出411.26万元,占总成交额3.36%,散户资金净流入1311.2万元,占总成交额10.72%。近5日资金流向一览见下表:海利生物主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100018349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","603718","BK0046","BK0239"],"gpt_icon":0},{"id":"2589570813","title":"海利生物(603718)披露拟收购控股子公司少数股权,12月05日股价上涨1.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589570813","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589570813?lang=zh_cn&edition=full","pubTime":"2025-12-05 22:25","pubTimestamp":1764944710,"startTime":"0","endTime":"0","summary":"截至2025年12月5日收盘,海利生物报收于7.18元,较前一交易日上涨1.7%,最新总市值为47.08亿元。根据近日发布的公告,上海海利生物技术股份有限公司拟收购控股子公司陕西瑞盛生物科技有限公司少数股东美伦管理有限公司持有的41%股权,交易作价3.993亿元,与美伦公司应退还的交易差价相抵,无需另行支付转让款。美伦公司继续履行2024至2026年累计净利润不低于23,300万元的业绩承诺,并将其持有的剩余4%股权质押给公司,已支付的5,000万元转为保证金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500040666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","603718","BK0070"],"gpt_icon":0},{"id":"2587967007","title":"海利生物最新公告:收购瑞盛生物少数股东权益无需支付股权转让款","url":"https://stock-news.laohu8.com/highlight/detail?id=2587967007","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587967007?lang=zh_cn&edition=full","pubTime":"2025-11-30 16:20","pubTimestamp":1764490818,"startTime":"0","endTime":"0","summary":"海利生物(603718.SH)公告称,公司与美伦管理有限公司签订《补充协议》,美伦公司应于2026年1月10日之前向公司退还3.993亿元的交易差价。因美伦公司资金周转困难,预计无法按期支付交易差价,建议以其持有的陕西瑞盛生物科技有限公司41%股权向公司履行交易差价退还义务。根据评估报告,目标股权交易作价为3.993亿元,与交易差价相抵后,公司本次收购瑞盛生物41%股权无需再支付股权转让款。本次交易完成后,公司持有瑞盛生物的股权比例由55%变更为96%。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025113000002775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603718","BK0070"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770116140226,"stockEarnings":[{"period":"1week","weight":-0.1681},{"period":"1month","weight":-0.0426},{"period":"3month","weight":-0.1633},{"period":"6month","weight":-0.2296},{"period":"1year","weight":-0.1793},{"period":"ytd","weight":-0.0426}],"compareEarnings":[{"period":"1week","weight":-0.0283},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.014},{"period":"6month","weight":0.1051},{"period":"1year","weight":0.2354},{"period":"ytd","weight":0.0118}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海海利生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"33808人(较上一季度增加7.16%)","perCapita":"19196股","listingDate":"2015-05-15","address":"上海市浦东新区中国(上海)自由贸易试验区临港新片区申港大道133号909室","registeredCapital":"65190万元","survey":" 上海海利生物技术股份有限公司的主营业务是体外诊断试剂(IVD)业务板块和口腔组织修复与再生材料业务板块。公司的主要产品是体外诊断试剂、口腔组织修复与再生材料。公司子公司捷门生物被认定为“上海市专精特新中小企业”、“上海市科技小巨人培育企业”,控股子公司瑞盛生物是陕西省瞪羚企业、陕西省“专精特新”中小企业和陕西省工业企业研发机构。","listedPrice":6.81},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海利生物(603718)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海利生物(603718)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海利生物,603718,海利生物股票,海利生物股票老虎,海利生物股票老虎国际,海利生物行情,海利生物股票行情,海利生物股价,海利生物股市,海利生物股票价格,海利生物股票交易,海利生物股票购买,海利生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海利生物(603718)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海利生物(603718)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}